Su‐Peng Yeh

11.1k citations
65 papers · 951 indexed · 1 hit paper · h-index 14

Impact in

  • Hematology top 2%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Multiple Myeloma Research and Treatments
  • Genetics top 5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 19
    • Multiple Myeloma Research and Treatments 10
    • Chronic Myeloid Leukemia Treatments 7
    • Chronic Lymphocytic Leukemia Research 11
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 10

Su‐Peng Yeh

60 papers receiving 943 citations

Hit Papers

Ivosidenib and Azacitidine in IDH1 -Mutated Acute Myeloid Leukemia 2022 · 295 citations
295202220262023202450100150200250

Peers

Su‐Peng Yeh
Comparison fields: 5 of 98
  • Hematology 514
  • Genetics 175
  • Cancer Research 112
  • Oncology 180
  • Molecular Biology 410
Replace Philipp Hemmati with:
Philipp Hemmati Germany
Claire Oudin France
Sarah Bertoli France
Madhu M. Ouseph United States
Marius Dohse Germany
Hila Magen Israel
Dorit Blickstein Israel
Antonia Miñano Spain
Liping Dou China
G. Ehninger Germany
Su‐Peng Yeh relative to Philipp Hemmati Germany Philipp Hemmati's profile →
Citations per field
00.5×9.6×
Philipp Hemmati · 1×
Citations per year

Countries citing papers authored by Su‐Peng Yeh

Since Specialization
Citations

This map shows the geographic impact of Su‐Peng Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su‐Peng Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su‐Peng Yeh more than expected).

Fields of papers citing papers by Su‐Peng Yeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su‐Peng Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su‐Peng Yeh. The network helps show where Su‐Peng Yeh may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Su‐Peng Yeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Su‐Peng Yeh Line = papers co-authored together Su‐Peng Yeh links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20240
3 20242
4 20234
5 20230
6 20222
7 20228
8 20229
9 20225
10 20183
11 201842
12 20183
13 20171
14 20169
15 201419
16 201214
17 201123
18 20091
19 20048
20 20003

About Su‐Peng Yeh

Su‐Peng Yeh is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Otorhinolaryngology, having authored 65 papers that have together received 951 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (13 papers), Chronic Lymphocytic Leukemia Research (11 papers), Multiple Myeloma Research and Treatments (10 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Protein Degradation and Inhibitors (7 papers), Chronic Myeloid Leukemia Treatments (7 papers) and Viral-associated cancers and disorders (5 papers). The work is most often cited by research in Hematology (514 citations), Genetics (175 citations), Cancer Research (112 citations), Oncology (180 citations) and Molecular Biology (410 citations). Su‐Peng Yeh has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Andre C. Schuh, Hartmut Döhner, Christian Récher, Jianxiang Wang, Diego A. Gianolio, Jianan Hui, Stéphane de Botton, Michael Heuser, Pau Montesinos and Rodrigo T. Calado. Their work appears in journals such as Blood, Journal of Clinical Oncology, International Journal of Hematology, Annals of Hematology and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026